|
WO2021022178A1
|
|
Substituted sulfonamide pyrrolopyridines as jak inhibitors
|
|
WO2021022186A1
|
|
Deuterated mk2 pathway inhibitors and methods of using the same
|
|
WO2020223728A1
|
|
Substituted pyrrolopyridines as jak inhibitors
|
|
CA3109192A1
|
|
Pyrrolopyrimidine itk inhibitors
|
|
KR20200083553A
|
|
Substituted pyrrolopyrimidine JAK inhibitors and methods of making and using the same
|
|
WO2019090143A1
|
|
Pyrazolyl pyrrolo[2,3-b]pyrimidine-5-carboxylate analogs and methods of making the same
|
|
US2019060311A1
|
|
Compositions and methods for treatment of vitiligo
|
|
US2018208594A1
|
|
Pyrrolopyrimidine ITK inhibitors for treating inflammation and cancer
|
|
KR20190039575A
|
|
Methods and compositions for the treatment of warts
|
|
WO2017091681A1
|
|
Selective kinase inhibitors
|
|
BR112016024630A2
|
|
topical composition and applicator
|
|
CN108478579A
|
|
Pyridone-pyridinyl compounds and application thereof
|
|
EP2648516A1
|
|
Substituted pyridinone-pyridinyl compounds
|
|
AU2007203283A1
|
|
Acrochordon alleviation
|
